Low-dose nab-paclitaxel-based combination chemotherapy in heavily pretreated pancreatic cancer patients

ConclusionIn heavily pretreated pancreatic adenocarcinoma patients, low-dose nab-paclitaxel-based chemotherapy was fairly tolerable with modest efficacy.
Source: Journal of the Formosan Medical Association - Category: General Medicine Source Type: research